Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications

Rheumatoid arthritis is an autoimmune disease that exhibits significant clinical heterogeneity. There are various treatments for rheumatoid arthritis, including disease-modifying anti-rheumatic drugs (DMARDs), glucocorticoids, non-steroidal anti-inflammatory drugs (NSAIDs), and inflammatory cytokine...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jianan, Guo, Shicheng, Schrodi, Steven J., He, Dongyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660630/
https://www.ncbi.nlm.nih.gov/pubmed/34899757
http://dx.doi.org/10.3389/fimmu.2021.790122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660630/
https://www.ncbi.nlm.nih.gov/pubmed/34899757
http://dx.doi.org/10.3389/fimmu.2021.790122

Ejemplares similares